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This will be a quasi-experimental study design with 
a goal of 60 patients about to undergo surgical or 
invasive procedures requiring an IV catheter 
insertion in the pre op department at West Kendall 
Baptist Hospital (WKBH).
Patient who receive, as standard of practice, 1% 
licocaine prior to IV insertion Will be compared to 
those that did not.
The study sample will consist of 60 patients aged 18 
years and older
To be included in the study participants have to 
have IV accesses established, and the ability to 
express their pain level.
The data collection tool of the study will consist of a 
questionnaire that include patient demographic 
information and questions about pain perception 
and anxiety experienced with IV insertion.
Eligible patients will be introduce to the study with a 
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• Use of antimicrobials including broad-spectrum antibiotics
has increased significantly over the years resulting in a rise in
resistance.
• The Infectious Disease Society of America supports the use
of rapid diagnostic testing to improve antibiotic utilization.
• Staphylococcus aureus (MSSA) and Methicillin-resistant
Staphylococcus aureus (MRSA) are common pathogens that
cause bloodstream infections.
• Vancomycin is often prescribed empirically until the strain
can be identified and in cases of MSSA de-escalated to a
more narrow spectrum antibiotic.
• Thus, rapid identification of staphylococcal species and
methicillin susceptibility has important implications in guiding
early optimal antibiotic therapy.
Determine if time to de-escalation of therapy is shortened
when methicillin sensitive staphylococcus aureus (MSSA) is
identified by rapid polymerase chain reaction (PCR) assay
compared to the conventional method of organism
identification by culture and sensitivity (C&S).
A quality assurance, retrospective cohort study was
conducted. Blood cultures positive for MSSA species
detected, by both polymerase chain reaction (PCR) rapid
diagnostic testing and by conventional clinical microbiology
procedures (C&S), were identified from the laboratory data
base.








The electronic health record (EHR) was used to collect:
Utilizing this data the following was calculated:
Interval in hours from culture collected to prescriber action
was compared for PCR results to conventional C&S results.
The median time to results (compared using a Wilcoxon rank
test) was significantly shorter in the PCR group compared to
the Conventional C&S group (z = 4.234, p < 0.001).
Ten of the 12 cases (83.3%) in the PCR group were de-
escalated to an antibiotic with narrower spectrum whereas 19
of the 29 cases (65.5%) for the Conventional C&S group were
de-escalated. These two proportions (compared using a chi-
square test) were not statistically significantly different
between the two groups (χ21df = 1.301, p = 0.254).
Preliminary data suggests a reduction in time to de-escalation
of antibiotic therapy for methicillin sensitive staphylococcus
bacteremias as a result of implementing PCR rapid diagnostic
testing. However, more data is needed to successfully
determine the impact on antibiotic consumption.
• Improve time for optimal treatment of MSSA
• Reduce the unnecessary use of Vancomycin
• Decrease the resistance to antibiotics
















29 19 75.4 ±24.7 70
PCR 12 10 20.3 ±6.1 19
The table below shows the descriptive statistics for the 2
groups: Conventional C&S and PCR.
The median time from culture collection to therapy de-
escalation (compared using a Wilcoxon rank test) was
significantly shorter in the PCR group compared to
Conventional C&S group (z = 4.125, p < 0.001).
Group Sample 
Size










17 101.4 ±59.3 80
PCR 9 32.4 ±12.9 30
•Time of Blood Cultures Collection
•Time of PCR Results
•Time of Conventional C&S Results
•Time of antibiotic therapy de-escalation
Time from blood culture 
collection to conventional  
C&S results
Time from blood 
culture collection 
to PCR results
Time from blood culture collection to 
antibiotic de-escalation
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